We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

4 hedge funds and large institutions have $65.7K invested in BioCardia, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less capital invested

Capital invested by funds: $73.2K → $65.7K (-$7.51K)

20% less funds holding

Funds holding: 5 → 4 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$4.46K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$37
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$27K +$4.46K +5,115 +17%
Osaic Holdings
2
Osaic Holdings
Arizona
$22.9K – – –
G
3
GenTrust
Florida
$11.5K – – –
Bank of America
4
Bank of America
North Carolina
$4.3K – – –
UBS Group
5
UBS Group
Switzerland
– -$37 -45 Closed

BCDAW Hedge Fund Activity: Q2 2023 in Review

4 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q2 2023, worth a combined $65.7K — down 10% from $73.2K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BCDAW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, adding an estimated $4.46K. The largest seller was UBS Group, exiting entirely with an estimated $37 sold.

  • 4 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q2 2023, down from 5 in Q1 2023.
  • Funds reported $65.7K of BioCardia, Inc. Warrant stock for Q2 2023, down 10% quarter-over-quarter.
  • 0 funds opened new BioCardia, Inc. Warrant positions in Q2 2023 and 1 closed out, a net change of -1 holder.
  • The largest BioCardia, Inc. Warrant buyer in Q2 2023 was Citadel Advisors, an estimated $4.46K added.
  • The largest BioCardia, Inc. Warrant seller in Q2 2023 was UBS Group, an estimated $37 sold.

Based on aggregated 13F filings for Q2 2023.